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Pulmonary Vein Ganglia Are Remodeled in the Diabetic Heart
Guillaume Bassil, MD; Mengmeng Chang, MD; Audrys Pauza, MS; Jesus Diaz Vera, BS; Athanasios Tsalatsanis, PhD; Bruce G. Lindsey, PhD;
Sami F. Noujaim, PhD
Background-—Cardiac autonomic neuropathy is thought to cause adverse cardiovascular effects in diabetes mellitus. Pulmonary
vein ganglia (PVG), which have been implicated in normal and abnormal heart rhythm regulation, have not been fully investigated in
type 1 diabetes mellitus (T1D). We examined the functional and anatomical effects of T1D on PVG and studied the details of T1D-
induced remodeling on the PVG structure and function.
Methods and Results-—We used a mouse model of T1D (Akita mouse), immunoﬂuorescence, isolated Langendorff-perfused hearts,
and mathematical simulations to explore the effects of T1D on PVG. Whole-mount atrial immunoﬂuorescence of choline
acetyltransferase and tyrosine hydroxylase labeling showed that sympathetic and parasympathetic somas of the PVG neurons were
signiﬁcantly hypotrophied in T1D hearts versus wild type. Stimulation of PVG in isolated Langendorff-perfused hearts caused more
pronounced P-P interval prolongation in wild type compared with Akita hearts. Propranolol resulted in a comparable P-P
prolongation in both phenotypes, and atropine led to more pronounced P-P interval shortening in wild type compared with Akita
hearts. Numerical modeling using network simulations revealed that a decrease in the sympathetic and parasympathetic activities
of PVG in T1D could explain the experimental results.
Conclusions-—T1D leads to PVG remodeling with hypotrophy of sympathetic and parasympathetic cell bodies and a concomitant
decrease in the PVG sympathetic and parasympathetic activities. ( J Am Heart Assoc. 2018;7:e008919. DOI: 10.1161/JAHA.
118.008919)
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T ype 1 diabetes mellitus (T1D) is increasing at analarming rate of about 4% per year.1 Consequently,
T1D is becoming a signiﬁcant public health burden.1,2 Cardiac
autonomic neuropathy (CAN) is a serious complication in
patients with diabetes mellitus.3 It is estimated that in T1D,
the prevalence of CAN is 40%.3 CAN is characterized by
both cholinergic/parasympathetic4,5 and noreadrenergic/
sympathetic dysfunction.5,6 CAN has been proposed to
increase the risk of silent myocardial infarction and sudden
cardiac death2,5 and serious cardiac arrhythmias including
atrial ﬁbrillation (AF).7,8
Multiple studies have suggested that there is a signiﬁcant
association between T1D and AF.9–13 CAN has been proposed
to contribute to AF in the diabetic heart; however, the exact
pathways are elusive.7,8 AF initiation and perpetuation
mechanisms include triggers that can originate from the
pulmonary veins14,15 with involvement of the pulmonary vein
ganglia (PVG).16–18 Nevertheless, it remains unclear if PVG are
remodeled in diabetes mellitus and if such remodeling could
affect heart rate regulation. We used a murine model of T1D
(Akita)19 to study the functional and anatomical effects of T1D
on the PVG. The Akita mouse is characterized by a mutation in
the ins2 gene, resulting in Ins2 cystein 96 to tyrosine
mutation. This leads to an insulin transport defect causing
destruction of pancreatic islet cells and subsequent develop-
ment of the T1D phenotype.19
In this study, we investigated, in detail—using confocal
microscopy, whole-heart electrophysiology, and numerical
simulations—whether T1D remodeled the PVG structure and
function.
Methods
Numerical simulation material relevant to this study is
available on reasonable request to the corresponding author.
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Animals
Our study conformed to the Guide for the Care and Use of
Laboratory Animals (National Institutes of Health Publication
no. 85-23, revised 1996) and was approved by the University
Committee on Use and Care of Animals of the University of
South Florida. Adult wild-type (WT; n=16) and Akita (n=16)
mice, aged 3 to 5 months, were purchased from the Jackson
Laboratory and used for experiments. Animals were hep-
arinized, and on induction with CO2 and following loss of
reﬂexes, cervical dislocation was performed and the heart was
quickly excised via thoracotomy.
Whole-Mount Atria Preparations
The samples were prepared as described previously.20 The
atria were gently dissected open, ﬂattened, and ﬁxed for
30 minutes in 4% paraformaldehyde at room temperature,
and then rinsed 3910 minutes in cold PBS.
Immunoﬂuorescence
As detailed earlier,20,21 the specimens were permeabilized for
1 hour with 0.5% Triton-X in PBS and blocked in 5% normal
donkey serum in PBS for 2 hours at room temperature. The
preparations were incubated in a mixture of primary antibod-
ies (polyclonal goat anti–choline acetyltransferase [anti-ChAT;
1:100] and polyclonal rabbit anti–tyrosine hydroxylase [anti-
TH; 1:500]) overnight at 4°C. After washing, they were
incubated in a mixture of secondary antibodies (Cy3-labeled
donkey antigoat [1:300] and FITC-labeled donkey antirabbit
[1:100]) for 4 hours at room temperature. Subsequently, the
preparations were mounted on glass slides using Vectashield
Mounting Medium (Vector Laboratories), covered with cover-
slips, and sealed with clear nail polish. For all antibodies used
in this study, negative controls were processed as outlined
and did not show any ﬂuorescent staining.
Confocal microscopy and image analysis
Fluorescent images were acquired using a Nikon A1R confocal
microscope (Nikon Instruments) and the built-in NIS-Elements
AR v4.20.01 software (Nikon Instruments). Images of intrac-
ardiac PVG were acquired. Fluorescence images in the Cy3
and FITC channels consisted of a series of z-stacks, 1-lm
thickness. Image analysis was performed using Fiji
software.22 The number of cells and the phenotype (ChAT
positive or TH positive) was determined by manually counting
the cell bodies throughout the optical projection in 3
dimensions. Cells were either ChAT positive only or bipheno-
typic (positive for both TH and ChAT). Purely TH-positive cells
were uncommon, as shown earlier.20,21 Ganglionic area was
determined in maximum-intensity Z-projection, whereas neu-
ronal size was determined by randomly selecting 10 to 20
neurons per ganglia and determining their area. Cell body
areas of ChAT-positive and of biphenotypic (ChAT and TH
positive) ganglionic neurons were calculated, and cumulative
frequency distributions of ChAT-positive and of biphenotypic
soma areas were plotted in Prism software (GraphPad
Software).
Karnovsky and Roots method for acetylcholinesterase
staining
Isolated Akita and WT hearts, cleaned from blood, were
perfused for 10 minutes with 4% paraformaldehype in 0.1M
PBS (pH=7.4). The hearts were dissected in ice-cold PBS to
expose the posterior left atrium and the sinoatrial node (SAN)
region. Subsequently, the hearts were further incubated in
paraformaldehyde at 4°C overnight. Afterward, the samples
were washed by incubation with PBS at 4°C on a rocker. We
used the Karnovsky and Roots method21,23 to stain for
acetylcholinesterase, allowing the visualization of both sym-
pathetic and parasympathetic nerve elements. The staining
medium contained 6 mmol/L Na acetate, 2 mmol/L acetylth-
iocholine iodide, 15 mmol/L sodium citrate, 3 mmol/L
CuSO4, 0.5 mmol/L K3Fe(CN)6, and 1% Triton- X (pH=5.6).
The hearts were incubated in the Karnovsky and Roots
medium for up to 12 hours at 4°C, and the incubation
medium was renewed every 3 to 6 hours. The stained hearts
were visualized using a dissection microscope coupled to a
5-megapixel CMOS camera (Moticam).
ECG Recordings and PVG Stimulation in Isolated
Langedroff-Perfused Hearts
The hearts of 13 WT and 13 Akita mice were isolated and
Langendorff-perfused, as described earlier.21 In short, the
excised heart was quickly cannulated and retrogradely
Clinical Perspective
What Is New?
• Type 1 diabetes mellitus leads to hypotrophy of pulmonary
vein ganglia somas and to decreased pulmonary vein ganglia
sympathetic and parasympathetic activities.
What are the Clinical Implications?
• Pulmonary vein ganglia autonomic disbalance can con-
tribute to heart rate dysregulation in diabetic cardiac
autonomic neuropathy.
• Restoring pulmonary vein ganglia sympathovagal balance
could have therapeutic effects on diabetic heart rhythm
control.
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perfused with HEPES-buffered tyrode solution bubbled with
100% O2, and the preparation was maintained at 361°C.
Volume-conducted ECG in lead II conﬁguration was
recorded using the PowerLab digitizer and the animal
BioAmp from AD Instruments. As we have done
previously,21 PVG was stimulated via a bipolar electrode
using high-frequency monophasic pulses (200 Hz, 300 ls,
and 400 lA; Stimulus Isolator, AD Instruments) applied in
trains of durations 300, 500, 700, and 1200 ms.21 Intervals
between trains were at least 2 minutes. Stimuli were
subthreshold for atrial myocardial excitation. The P-P
intervals were measured before and after stimulation in
the absence and presence of 100 lmol/L propranolol and/
or 10 lmol/L atropine in the perfusate.
Numerical Network Simulations
Network simulations were performed using a previously
described “integrate-and-ﬁre” modeling approach24 based
on the SYSTM11 program by MacGregor,25 implemented
using the C language in the UNIX environment. The
excitability of each cell population was regulated by
synaptic currents, an injected current, and noise added to
provide variability. Slow activity-dependent dynamics of the
threshold for spike generation were incorporated in some
populations. Electrical stimulation of the system was
simulated as synaptic inputs from “ﬁber populations”
turned on at a speciﬁed time in the simulation run.
Parameters for the cell populations in the simulated circuit
are in Table 1. The variables used for each population were
as described by Rybak.24 Brieﬂy, the resting thresholds for
each population were normally distributed around the value
Table 1. Population Parameters for Simulated Circuit
Cell Parameters Population
SA
Node ChAT ChAT+TH Stimulus
Cells in population, n 1 15 8 10
Resting threshold, mV 10 10 10 10
Resting threshold
variability, mV
0 2 2 2
Membrane time
constant, ms
5 9 9 9
Postspike increase in
potassium conductance
20 20 20 20
Postspike potassium
conductance time constant
100 7 7 10
Adaptation threshold increase 0.1 0.0 0.0 0.3
Adaptation time constant, ms 25 500 500 500
Noise amplitude 0.0 0.005 0.01 0.2
DC injected current, mV 11.7 10.5 10.1 0.0
Table 2. Connectivity parameters for the simulated circuit
Connectivity Parameters Simulation Parameter Value
Fiber connections to stimulus population Excitatory fibers
Fibers, n 100
Terminals, n 9
Firing probability at each simulation time step (1.0 ms) 0.05
Synaptic weight 0.002
Synaptic type and time constant (ms) Excitatory
Time constant (ms) 100
Cell populations Stim?ChAT Stim?ChAT+TH Ach?ChAT+TH ChAT?SAN ChAT+TH?SAN
Synaptic type Excitatory Excitatory Inhibitory Inhibitory Excitatory
Time constant (ms) 5 5 2 500 5
Min. conduction time (ms) 2 2 2 2 2
Max. conduction time (ms) 2 2 6 6 6
Terminals WT: 13
AK: 15
WT: 12
AK: 12
WT: 14
AK: 8
WT: 5
AK: 7
3
Synaptic weight WT: 0.027
Akt: 0.035
WT: 0.0044
Akt: 0.01
WT: 0.001
Akt: 0.000005
Atropine: 0
WT: 0.000005
Akt: 0.000002
Atropine: 0
WT: 0.0005
Akt: 0.0002
PR: 0
Ach indicates acetylcholinesterase; Akt, Akita; ChAT, choline acetyltransferase; PR, propranolol; Stim, stimulation; TH, tyrosine hydroxylase; WT, wild type.
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of the resting threshold with a standard deviation equal to
the variability parameter value (Table 1). Noise amplitude is
the conductance added to synaptic conductances produced
by each cell’s internal noise generator, which acts like 2
synapses, one with an equilibrium potential of 70 mV above
and the other 70 mV below resting threshold. These inputs
have a time constant of 1.5 ms and ﬁring probabilities of
0.05 per time step. The DC injected current, speciﬁed in
millivolts, raises the membrane potential by an amount that
is inversely proportional to the membrane conductance and
is interpreted as the current that is required to raise the
membrane potential by the speciﬁed number of millivolts
when the membrane conductance is at its resting value. At
other membrane conductances, the effect on the mem-
brane potential is inversely proportional to the conductance.
Parameter values for the ﬁber population that generated
the stimulus and for connections among the cell popula-
tions are in Table 2. Excitatory synapses had an equilibrium
potential of 115.0 mV; inhibitory synapses had an equilib-
rium potential of 25.0 mV.
Statistical Analysis
Data were plotted and presented as averageSE. A 2-sample
t test, or Wilcoxon rank sum test, as well as paired a t test or
Wilcoxon signed rank test were used, as appropriate. When
Wilcoxon tests were applied, the median and interquartile
range (IQR) were also reported. Signiﬁcance was taken at
P<0.05. Analysis was performed in SAS/STAT v14.3 (SAS
Institute). Gaussian cumulative distributions were ﬁtted to cell
body areas using GraphPad Prism v7.0b.
Results
Somas of PVG Neurons Are Hypotrophied in the
Diabetic Heart
To quantify possible remodeling of the PVG in the Akita
diabetic heart, we performed immunoﬂuorescence confocal
microscopy of the mouse atria in whole-mount preparations
stained with the sympathetic marker TH and the parasympa-
thetic marker ChAT. A WT heart is shown in Figure 1. We then
quantiﬁed the areas of somas in PVG of WT and Akita hearts.
Somas were either ChAT positive (parasympathetic) or
biphenotypic ChAT and TH positive (sympathetic), as we and
others have shown previously.20,21 Figure 2 is a high-
magniﬁcation image of the PVG boxed in white in Figure 1.
Green is TH (Figure 2A, left panel), red is ChAT (middle panel),
and the right panel is the merged image. Cumulative
frequency distributions of ganglionic cell areas in WT and
Akita PVG are shown in Figure 2B, in which ChAT and
biphenotypic somas of PVG neurons in Akita hearts were
atrophied and had a signiﬁcantly smaller mean area compared
with their WT counterparts. In Figure 2B (left), the cumulative
frequency distribution of ChAT-positive cell body area showed
that the mean area was 130.20.22 lm2, R2=0.99 (N=3
hearts, n=160 cells), for WT and 118.40.25 lm2, R2=0.99
(N=3, n=161 cells), for Akita (P<0.001, WT versus Akita). The
cumulative frequency distribution of biphenotypic cell body
areas in Figure 2B (right) showed that the mean soma area
was 141.70.161 lm2, R2=0.99 (N=3, n=152 cells), for WT
and 1270.36 lm2, R2=0.99 (N=3, n=150 cells), for Akita
(P<0.001, WT versus Akita). These results indicated that the
parasympathetic and biphenotypic somas of PVG are hypotro-
phied in the Akita heart.
Innervation of the SAN by the PVG Is Intact in the
Diabetic Heart
PVG innervates the SAN in humans and in rodents, and these
nerve connections are similar between the 2 species.21,26 We
used qualitative acetylcholinesterase staining, as we have
done previously,21,26 to investigate whether diabetes mellitus
disrupts the connections between PVG and the SAN.
Figure 3A and 3B are images of stained WT and Akita hearts.
PVG in the posterior left atrium are indicated by white double
SVC 
IVC 
RA 
LA 
Ao
PV 
1 mm 
Figure 1. Immunoﬂuorescence of murine atrial intrinsic ganglia.
Whole-mount atrial preparation from a wild-type heart stained
with tyrosine hydroxylase (green) and choline acetyltransferase
(red). The pulmonary vein ganglion boxed in white is shown at
higher magniﬁcation in Figure 2. Ao indicates aorta; IVC, inferior
vena cava; LA, left atrium; PV, pulmonary veins; RA, right atrium;
SAN, sinoatrial node; SVC, superior vena cava.
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arrows. Nerves emerge from these ganglia, advance into the
right atrium, and proceed to innervate the SA node (triple
arrow heads). Figure 3C and 3E are enlarged views of the SAN
area (boxed in white), showing intact innervation originating
from the PVG in both WT and Akita hearts. Figure 3D and 3F
show 920 magniﬁcation of the PVG (white double arrows) in
Figure 3A and 3B. These experiments suggested that diabetes
mellitus did not cause anatomical disruption of the nerves
that emerge from the PVG and advance to innervate the SAN.
Diabetes Mellitus Alters the Regulation of Heart
Rate by PVG
We demonstrated in an earlier study that PVG stimulation
modulated the heart rate. In this study, we investigated whether
diabetes mellitus affected the regulation of the heart rate by
PVG. In isolated Langendorff-perfused hearts, PVG was stim-
ulated with a bipolar electrode using high-frequency monopha-
sic pulses applied in trains of durations 300, 500, 700, and
1200 ms.21 This stimulation regimen stimulates neurons but is
subthreshold for cardiomyocytes.21 Figure 4A shows ECG
traces of WT and Akita hearts. When a 700-ms stimulus was
applied to the PVG region, the P-P interval after stimulation was
longer in the WT compared with the Akita heart. Figure 4B
shows the P-P intervals of the 20 beats immediately following
PVG stimulation in WT and Akita hearts. In control conditions,
the P-P intervals after PVG stimulation were signiﬁcantly longer
in the WT hearts compared with Akita (P<0.001). In the
presence of propranolol, which blocks sympathetic signaling,
the P-P intervals were prolonged in the WT and Akita hearts
(P=0.3). We then blocked parasympathetic signaling with
atropine to investigate the unopposed effects of the sympa-
thetic PVG tone. Stimulation caused a more pronounced
decrease in the P-P interval of the WT hearts compared with
Akita (P<0.001). In Figure 4C (left), the averaged P-P intervals
of the 3 beats before PVG stimulation and those of 3 beats right
after PVG stimulation are plotted. In control, stimulation
prolonged the WT P-P interval from 205.67.5 ms (median:
211.3 ms; IQR: 173.8-248.8 ms) before stimulation to
317.811.5 ms (median: 315 ms; IQR: 276.9-353.1 ms) after
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Figure 2. Quantiﬁcation of pulmonary vein ganglia (PVG) soma size. A, Immunoﬂuorescence of mouse
PVG. Tyrosine hydroxylase (TH, green) and choline acetyltransferase (ChAT, red). The PVG boxed in white in
Figure 1 is shown at higher magniﬁcation. B, The white arrows point to nerve containing ChAT- and TH-
positive ﬁbers. Cumulative frequency distribution of ganglionic neuronal cell body areas of ChAT-positive
and of biphenotypic (ChAT- and TH-positive) cells. Cells that are only TH positive were not common. The left
panel shows cumulative frequency distribution of ChAT-positive cell body area, where the mean soma size
was 130.20.22 lm2, R2=0.99 (N=3 hearts, n=160 cells) for wild-type (WT) and 118.40.25 lm2,
R2=0.99 (N=3, n=161 cells) for Akita hearts (P<0.001). The right panel shows cumulative frequency
distribution of biphenotypic cell body areas, where the mean soma size was 141.70.161 lm2, R2=0.99
(N=3, n=152 cells) for WT and 1270.36 lm2, R2=0.99 (N=3, n=150 cells) for Akita hearts (P<0.001).
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stimulation (P<0.001). In Akita hearts, the P-P interval was
prolonged, from 167.85.7 ms (median: 182.4 ms; IQR:
155.6-209.2 ms) to 218.95.1 ms (median: 209.6 ms; IQR:
190-229.2 ms; P<0.001). In the presence of 1 lmol/L
propranolol (Figure 4C, middle), the WT P-P interval was
prolonged signiﬁcantly, from 235.213.4 ms (median:
208.4 ms; IQR: 163.8-253 ms) before stimulation to
407.122.6 ms (median: 432.4 ms; IQR: 351.3-514.6 ms)
after stimulation (P<0.001). In Akita, the prolongation was also
signiﬁcant, from 211.97.5 ms (median: 212.5 ms; IQR:
174.6-250.4 ms) to 348.916.1 ms (median: 312.8 ms; IQR:
232.9-392.8 ms; P<0.001). Finally, with 10 lmol/L atropine
(Figure 4C, right), stimulation signiﬁcantly shortened the P-P
interval in WT hearts from 199.52.5 ms (median: 201.5 ms;
IQR: 196.8-206.3 ms) before to 176.46.4 ms (median:
176 ms; IQR: 160.8-191.3 ms) after stimulation (P=0.003)
and in Akita hearts from 202.36.76 ms (median: 210 ms;
IQR: 184.5-235.5 ms) before to 195.97.1 ms (median:
182 ms, IQR: 156-208 ms) after stimulation (P=0.031).
We then computed the change in P-P interval (difference
between the average of 3 beats before and 3 beats after PVG
stimulation) as a function of stimulus train duration in the
control (Figure 5A) and in the presence of propranolol
(Figure 5B), atropine (Figure 5C), or propranolol plus atropine
(Figure 5D). Figure 5A shows that at stimulus of 300 ms
(P=0.046), 700 ms (P=0.0022), and 1200 ms (P=0.0018), the
increase in P-P interval was signiﬁcantly larger in WT than
Akita hearts. After sympathetic blockade with propranolol
(Figure 5B), although not signiﬁcant (P=0.095 at 300-ms
stimulus duration, P=0.791 at 500 ms, P=0.109 at 700 ms,
and P=0.244 at 1200 ms), the increase in P-P interval tended
to be larger in WT animals at 700- and 1200-ms trains. After
parasympathetic blockade with atropine (Figure 5C), the
decrease in P-P interval was signiﬁcantly more pronounced
in WT than Akita hearts at 300-ms (P=0.022), 500-ms
(P=0.034), and 1200-ms (P=0.012) trains. Blocking both
sympathetic and parasympathetic signaling (Figure 5D)
blunted the effects of PVG stimulation on the P-P interval,
and thus there was no difference in WT versus Akita hearts
(P=0.122 at 300 ms, P=0.576 at 500 ms, P=0.096 at
700 ms, and P=0.467 at 1200 ms).
The results of Figures 4 and 5 indicate that T1D altered the
sympathovagal balance of the PVG tone. PVG contain
parasympathetic (ChAT-positive) somas (Figures 1 and 2)
and sympathetic (TH- and ChAT-positive) somas (Figures 1
and 2).20,21 When PVG was stimulated in control conditions,
P-P interval prolongation was more pronounced in WT
compared with Akita hearts. Initially, this indicated to us that
the net output of the Akita PVG is shifted more toward a
sympathetic tone and that this could be achieved by a simple
increase in the sympathetic activity of the Akita PVG neurons.
However, when parasympathetic signaling was blocked with
atropine, leaving sympathetic activity unopposed, stimulation
caused a signiﬁcant decrease of the P-P interval of the WT but
WT Akt
SVC SVC 
PLA 
PLA 
LA 
LA 
RA RA 
A B
Ao
Ao
SAN SAN 
SAN SAN 
C D E F 
0.5 mm 
0.5 mm 
Figure 3. Acetylcholinesterase staining of wild-type (WT) and Akita (Akt) atria. A and B, Stained WT and
Akita hearts respectively. Pulmonary vein ganglia (PVG) are indicated by white double arrows. Triple
arrowheads indicate nerves projecting from PVG to the sinoatrial node (SAN). C and E, Enlarged views of
the SAN area boxed in white in WT and Akita hearts. D and F, 920 magniﬁcation of the PVG (white double
arrows) in panels A and B. Ao indicates aorta; LA, left atrium; PLA, posterior left atrium; RA, right atrium;
SVC, superior vena cava.
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not the Akita hearts. This implied that the sympathetic activity
of PVG neurons is in fact reduced in Akita compared with WT
hearts. Consequently, we hypothesized that the stronger net
sympathetic tone of the Akita PVG (Figures 4A–4C and 5A)
could be due to a decrease in both the sympathetic and
parasympathetic activities of the PVG neurons. To test this
hypothesis, we performed mathematical modeling using
network simulations.
Modeling the Effects of Diabetes Mellitus on the
Regulation of the P-P Interval by PVG
Network simulations were performed using a previously
described modeling approach.24,25 The circuit in Figure 6A
was formed by an excitatory population of 10 cells (Stim) that
simulated the excitation provided by the bipolar electrode in
the experiment. The ganglion was modeled as a population of
15 ChAT-positive parasympathetic cells and 8 biphenotypic
ChAT- and TH-positive sympathetic cells. Ganglionic parasym-
pathetic neurons are hypothesized to have inhibitory connec-
tions with both the SAN cell and the ganglionic sympathetic
neurons. Ganglionic sympathetic neurons are hypothesized to
excitatory connections with the SA node. Thus, the ﬁber
projecting from the ganglion to the SAN cell has sympathetic
and parasympathetic ﬁbers, as also seen in the immunoﬂu-
orescence experiment of Figure 2A and as we have previously
shown.21 Each cell population was regulated by synaptic
currents, an injected current, and noise added to provide
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Figure 4. Modulation of the P-P interval in the isolated Langendorff-perfused wild-type (WT) and Akita (Akt) mouse hearts by pulmonary vein
ganglia (PVG) stimulation. A, ECG traces from WT and Akita hearts. The P-P intervals of the 3 beats before and after stimulation were measured.
Stim=700-ms stimulation. B, P-P intervals of the 20 beats following 700-ms stimulation of the PVG in control (WT, n=7; Akt, n=7), propranolol
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variability. Slow activity-dependent dynamics of the threshold
for spike generation were incorporated in some populations.
Electrical stimulation of the system was simulated as synaptic
inputs from a cell population (Stim) turned on at a speciﬁed
time in the simulation run. The population parameters are in
Table 1, and the connectivity parameters are in Table 2. In WT
settings, stimulation initiation (black arrow in Figure 6B)
resulted in acceleration of ﬁring the ChAT and biphenotypic
ganglionic cell population and in the slowing down the SAN
cell ﬁring rate. Diabetes mellitus was modeled as smaller
synaptic weights of the sympathetic and parasympathetic
synaptic parameters compared with WT to simulate a
reduction in the sympathetic and parasympathetic activities
of the PVG neurons (table 2). Figure 6C shows the simula-
tions results, and Figure 6D shows the experimental results at
700-ms stimulus duration (from Figure 5). In simulations,
under control conditions, the change in P-P interval (D P-P) is
larger in WT compared with Akita hearts. The effects of
propranolol in WT and Akita hearts were simulated as
reduction to 0 in the synaptic weight of the excitatory
synapse between sympathetic cells and the SAN cell
(Table 2). This resulted in more pronounced prolongation of
the P-P interval in WT compared with Akita hearts. Atropine in
WT and Akita hearts was simulated as a decrease to 0 in the
synaptic weight of the inhibitory synapse between parasym-
pathetic cells and the SAN cell and in the inhibitory synapse
interconnecting the sympathetic and parasympathetic neu-
rons in the PVG (Table 2). This resulted in more pronounced
reduction the P-P interval in WT compared with Akita hearts.
The simulation results (Figure 6C) agree with the experimen-
tal results reproduced in Figure 6D.
Discussion
We show that T1D induces dystrophic changes in the PVG
where parasympathetic and sympathetic neuronal cell bodies
atrophy in the diabetic heart. In addition, stimulation of the
PVG in the isolated Langendorff-perfused heart resulted in
blunted P-P interval prolongation in the diabetic heart
compared with WT. This suggested that the net output of
the Akita PVG tone could be sympathetically shifted. PVG
stimulation in the presence of propranolol led to P-P interval
prolongation in both the diabetic and WT hearts, and atropine
caused a larger decrease in the WT P-P interval. Treatment
with atropine and propranolol together abrogated the effects
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Figure 5. Average change in P-P interval of the ﬁrst 3 beats after stimulation. Change in P-P interval after
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[Akt], n=7), (B) propranolol (WT, n=8; Akt, n=8), (C) atropine (WT, n=5; Akt, n=5), and (D) propranolol plus
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of PVG stimulation on the P-P interval. Mathematical modeling
using network simulations suggested that in diabetes mellitus,
a decrease in the PVG sympathetic and parasympathetic
activities could explain the experimental results.
Our whole-mount atrial immunoﬂuorescence of ChAT and
TH labeling showed a signiﬁcant decrease in the surface area
of PVG somas in diabetic compared with WT hearts. This
correlates with what has been shown in previous studies27–29
of streptozocin-induced T1D mice and rats and in human
hearts30 where cell bodies of intrinsic cardiac neurons
displayed dystrophic features. The mechanism behind this
remodeling is poorly understood, although it was hypothe-
sized that the extracellular hyperosmolarity caused by hyper-
glycemia could cause neuronal osmotic shrinkage, which
might affect neuronal activity.27,31 It was recently shown by
Mabe et al29 that heart rate dysregulation in chemically
induced T1D via streptozocin injection in mice was upstream
of atrial/nodal tissue, and neurodystrophic changes of atrial
innervation at the level of nerve endings were not observed.
Remodeling of the intrinsic cardiac and extrinsic nervous
systems could occur in diabetic CAN. Moreover, the intrinsic
cardiac nervous system, which includes PVG, plays a role in
heart rate regulation,32 and its malfunction may facilitate
arrhythmogenesis.15,33,34 PVG has signiﬁcant sympathetic
and parasympathetic connections to the SAN in humans and
in rodents, and these connections are very similar between
the 2 species.21,26 It has been shown in patients that T1D
could result in a more dominant sympathetic regulation of
heart rate.35–39 Our results under control conditions sug-
gested a stronger net sympathetic tone at the level of the PVG
output in the diabetic mice.
PVG is thought to play a role in the initiation and perpetuation
of AF. Triggers of AF can originate from the pulmonary veins,14
and studies suggested that ablation of PVG can terminate
AF.16–18 Consequently, the alteration of sympathetic and
parasympathetic balance within the PVG can conceivably
participate in the mechanism of heart rate dysregulation and
diabetic AF. However, it should be noted that the
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Figure 6. Numerical model. A, A ganglion was modeled as having 15 choline acetyltranferase positive cells, and 8 biphenotypic (tyrosine
hydroxylase and choline acetyltranferase positive cells). The nerve projecting from the ganglion to the sinoatrial node (SAN) cell has sympathetic
and parasympathetic ﬁbers. B, Action potentials from the different components of the circuit. Stim shows the time when stimulation is on. ChAT
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C, Simulated SAN action potential cycle length changes (D P-P) in wild-type (WT) and Akita (Akt) cases without and with propranolol or atropine.
D, Experimental data from Figure 5 (700-ms stimulus duration) showing good agreement between numerical and experimental data. ChAT
indicates choline acetyltransferase; TH, tyrosine hydroxylase.
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pathophysiological changes in diabetes mellitus leading to
increased susceptibility to AF do not only revolve around
autonomics. Electrical, electromechanical, and structural
remodeling take place.40 For instance, diabetic cardiomyopathy
is characterized by myocardial hypertrophy, myocardial lipo-
toxicity, oxidative stress, cellular apoptosis, interstitial ﬁbrosis,
contraction–relaxation dysfunction, and mitochondrial dys-
function.40 These processes can also contribute to the initiation
and maintenance of AF in the diabetic heart.
T1D is increasing at an alarming rate.1 It is estimated that 5%
to 15% of adults diagnosed with type 2 diabetes mellitus are
misdiagnosed and actually have T1D.2 In diabetic CAN, both
branches of the autonomic nervous system were shown to be
affected.5 Perturbations of the cardiac sympathovagal balance
by diabetes mellitus could contribute to arrhythmogenesis.2,5 It
was shown that in patients with T1D, b-blockade modiﬁed the
sympathovagal balance; it reduced the sympathetic tone,
reduced inﬂammation, and normalized heart rate variability.41
In addition, parasympathetic variables of heart rate variability
improved in T1D patients with CAN treated with quinapril, an
angiotensin-converting enzyme inhibitor.42 It thus seems
plausible that modulation of cardiac autonomics in diabetes
mellitus could have therapeutic effects.43 It remains to
be determined whether long-term cardiac autonomic
modulation,44 speciﬁcally, restoring the PVG sympathovagal
balance, reduces the occurrence of adverse effects in cardiac
rhythm and function in T1D.
Limitations
Our experiments were performed in the isolated heart.
Although likely, it is still unclear whether PVG remodeling by
diabetes mellitus could affect regulation of the heart rate
in vivo. It has been shown using ECG telemetry that
parameters of heart rate variability are affected by diabetes
mellitus in the Akita mouse45 and that those changes do
suggest sympathetic and parasympathetic dysfunction similar
to our experiments in this study.45 At present, however, it is
difﬁcult to isolate, in vivo, the effects of diabetes mellitus on
the PVG regulation of the heart rate in the mouse. In addition,
the intrinsic cardiac nervous system is extensive and is
composed of ganglionated plexi located in several regions of
the atria.32 These ganglionated plexi have been shown to
participate in modulating SAN activity.32 In this study, we
focused on the PVG given their demonstrated role in normal
and abnormal heart rhythm regulation, namely, AF.16–18
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